🔎 Trials Near Me

Почетна › Плоскоклеточни карцином главе и врата › Охајо

Kliničke studije za Плоскоклеточни карцином главе и врата u državi Охајо

46 studija za Плоскоклеточни карцином главе и врата traži učesnike na lokacijama u državi Охајо.

Gradovi u državi Охајо

Zvanični tekst studije (na engleskom)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • Miami Valley Hospital South, Centerville
  • Cleveland Clinic Foundation, Cleveland
  • Premier Blood and Cancer Center, Dayton
  • и још 4
Тражи се учесникФаза 2
Узраст од 18 до 79 · Оба пола · Ажурирано 12. 11. 2026. · NCT04671667

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Miami Valley Hospital South, Centerville
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • и још 3
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05136196

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • Miami Valley Hospital South, Centerville
  • Miami Valley Hospital, Dayton
  • Miami Valley Hospital North, Dayton
  • и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06589804

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06627270

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

  • Aultman Health Foundation, Canton
  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06992427

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

  • Cleveland Clinic, Cleveland
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06385080

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  • University of Cincinnati, Cincinnati
  • Ohio State University, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07276399

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  • University of Cincinnati, Cincinnati
Тражи се учесникФаза 3
Узраст 60 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT04892173

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • Cleveland Clinic, Cleveland
  • Ohio State University, Columbus
  • Taylor Cancer Research Center, Maumee
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT03526835

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Mercy Hospital (Site#0154), Canton
  • University of Cincinnati Cancer Institute (Site#0117), Cincinnati
  • University Hospitals Seidman Cancer Center (Site #0151), Cleveland
  • и још 1
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06788990

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • UH Cleveland Medical Center, Cleveland
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06980038

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • Ohio State University, Columbus
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06769698

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 138, Canton
  • Research Site 113, Cincinnati
  • Research Site 131, Dayton
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116

SMP-3124LP in Adults With Advanced Solid Tumors

  • Ohio State University, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT06526819

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

  • Univ Hosp Cleveland /ID# 257706, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06084481

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  • Gabrail Cancer Center and Research Center, Canton
  • Cleveland Clinic Main Campus, Cleveland
  • The Ohio State University Comprehensive Cancer Center The Arthur G.James, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07768189

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Cleveland Clinic, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04429542

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #10, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05176483

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

  • Site 06, Maumee
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07814248

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 10, Columbus
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07085091

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • UH Seidman Cancer Center at UH Avon Health Center, Avon
  • Indu and Raj Soin Medical Center, Beavercreek
  • Saint Elizabeth Boardman Hospital, Boardman
  • и још 22
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT02734537

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Cleveland Clinic, Cleveland
  • Toledo Clinic Cancer Center, Toledo
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT05059444

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

  • Research Site, Columbus
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT06535607

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • Cleveland Clinic, Cleveland
  • Ohio State University, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT06657222

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • University of Cincinnati, Cincinnati
  • Cleveland Clinic, Cleveland
  • Ohio State University, Columbus
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06163534

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Maumee
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  • Cleveland Clinic Foundation, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • Summa Health System - Akron Campus, Akron
  • Aultman Health Foundation, Canton
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06532279

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

  • The Ohio State University, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 8. 2026. · NCT05985655

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 24. 7. 2026. · NCT04754321

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • UH Cleveland Medical Center, Cleveland
  • Stefanie Spielman Comprehensive Breast Center, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

  • University of Cincinnati Medical Center, Cincinnati
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT07213934

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, Canton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 26. 5. 2026. · NCT06256588

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

  • University of Cincinnati Medical Center, Cincinnati
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 18. 5. 2026. · NCT07497607

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

  • The Cleveland Clinic Foundation, Cleveland
Тражи се учесникФаза 2/3
Узраст од 18 до 100 · Оба пола · Ажурирано 23. 4. 2026. · NCT05893888

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 4. 2026. · NCT06064877

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

  • Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 4. 2026. · NCT05785741

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.